Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 388, Issue 9, 2015, Pages 905-919

  Bułdak, Łukasz ^a   Łabuzek, Krzysztof ^a   Bułdak, Rafał Jakub ^a   Machnik, Grzegorz ^a   Bołdys, Aleksandra ^a   Okopień, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Catalase; Exenatide; GLP 1; Glutathione peroxidase; LPS; Superoxide dismutase

Indexed keywords

CATALASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; EXENDIN 4; GLUTATHIONE PEROXIDASE; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; ANTIDIABETIC AGENT; ANTIOXIDANT; GLUCAGON LIKE PEPTIDE 1; MALONALDEHYDE; PEPTIDE; VENOM;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MALE; MONOCYTE; NORMAL HUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEIOTROPY; PROTEIN EXPRESSION; ADOLESCENT; AGONISTS; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIOXIDANTS; CELLS, CULTURED; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIC AGENTS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MALONDIALDEHYDE; MONOCYTES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEPTIDES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; VENOMS; YOUNG ADULT;

EID: 84939269741     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-015-1124-3     Document Type: Article

References (28)

1. Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T et al (2010) Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes 59(4):1030-1037
2. Biswas SK, Mantovani A (2012) Orchestration of metabolism by macrophages. Cell Metab 15(4):432-437
3. Buldak L, Łabuzek K, Bułdak RJ, Kozłowski M, Machnik G, Liber S et al (2014) Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages. Pharmacol Rep 66(3):418-429
4. Bułdak RJ, Bułdak Ł, Polaniak R, Kukla M, Birkner E, Kubina R et al (2013) Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rep 29(2):771-778
5. Chang G, Zhang D, Yu H, Zhang P, Wang Y, Zheng A et al (2013a) Cardioprotective effects of exenatide against oxidative stress-induced injury. Int J Mol Med 32(5):1011-1020
6. Chang S-Y, Kim D-B, Ryu GR, Ko S-H, Jeong I-K, Ahn Y-B et al (2013b) Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP/PKA pathway. J Cell Biochem 114(4):844-853
7. Chang G, Zhang D, Liu J, Zhang P, Ye L, Lu K et al (2014) Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells. Exp Biol Med Maywood NJ 239(4):414-422
8. Chaudhuri A, Ghanim H, Vora M, Sia CL, Korzeniewski K, Dhindsa S et al (2012) Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab 97(1):198-207
9. Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D et al (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 372(9645):1240-1250
10. Foronjy RF, Mirochnitchenko O, Propokenko O, Lemaitre V, Jia Y, Inouye M et al (2006) Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am J Respir Crit Care Med 173(6):623-631
11. Fujimoto H, Kobayashi H, Ohno M (2010) Age-induced reduction in mitochondrial manganese superoxide dismutase activity and tolerance of macrophages against apoptosis induced by oxidized low density lipoprotein. Circ J 74(2):353-360
12. Hendarto H, Inoguchi T, Maeda Y, Ikeda N, Zheng J, Takei R et al (2012) GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. Metabolism 61(10):1422-1434
13. Ishibashi Y, Nishino Y, Matsui T, Takeuchi M, Yamagishi S (2011) Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level. Metabolism 60(9):1271-1277
14. Kaplan M, Aviram M, Hayek T (2012) Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy. Pharmacol Ther 136(2):175-185
15. Labuzek K, Liber S, Bułdak L, Krupej-Kędzierska J, Machnik G, Bobrzyk M et al (2014) Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers. Eur J Pharmacol 726C:96-108
16. Liu J, Wang H, Wang Y, Yin Y, Wang L, Liu Z et al (2014) Exendin-4 pretreated adipose derived stem cells are resistant to oxidative stress and improve cardiac performance via enhanced adhesion in the infarcted heart. PLoS One 9(6):e99756
17. Maechler P, Jornot L, Wollheim CB (1999) Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 274(39):27905-27913
18. Morgan D, Oliveira-Emilio HR, Keane D, Hirata AE, Santos da Rocha M, Bordin S et al (2007) Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia 50(2):359-369
19. Mukai E, Fujimoto S, Sato H, Oneyama C, Kominato R, Sato Y et al (2011) Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner. Diabetes 60(1):218-226
20. Murata Y, Shimamura T, Tagami T, Takatsuki F, Hamuro J (2002) The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2(5):673-689
21. Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J et al (2011) Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia 54(10):2649-2659
22. Ojima A, Matsui T, Maeda S, Takeuchi M, Yamagishi S (2012) Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties. Horm Metab Res Horm Stoffwechselforschung Horm Métabolisme 44(7):501-505
23. Okopien B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M et al (2005) Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates. J Cardiovasc Pharmacol 46(3):377-386
24. Park J-G, Oh GT (2011) The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep 44(8):497-505
25. Rice P, Longden I, Bleasby A (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet TIG 16(6):276-277
26. Sathananthan M, Farrugia LP, Miles JM, Piccinini F, Dalla Man C, Zinsmeister AR et al (2013) Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects. Diabetes 62(8):2752-2756
27. Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176(1):287-292
28. Van Dyken SJ, Locksley RM (2013) Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 31:317-343